In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Veracyte: How To Build A Molecular Cytology Company

Executive Summary

Veracyte has launched a complex molecular diagnostic test in thyroid in record time and with impressive capital efficiency. It could be a model for high-value diagnostics, especially if the company can successfully adopt its approach in a broader market.

Advertisement

Related Content

Veracyte Moves Into Lung Cancer MolDx With $21 Million Allegro Buy
Option Deal Structure Works For Myriad As It Moves To Buy Crescendo
Option Deal Structure Works For Myriad As It Moves To Buy Crescendo
The A-List: The Trend-Shaping Series A Financings Of 2013
2013: The Year In Diagnostics
Systems Biology Goes Commercial As Integrated Diagnostics Launches Lung Nodule Test
Financings Of The Fortnight: Do Larger Series A Rounds Mean Less Successful Exits?
The Balkanized State Of Molecular Diagnostics Reimbursement
CardioDx: Bringing Molecular Diagnostics Into the Cardiovascular Arena

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel